machine learning Archives - European Biotechnology Magazine

Tag Archive for: machine learning

Accelerating and derisking antibody drug development by early lead panel optimization. Picture:©Yumab GmbH

Derisking drug programs by early lead optimisation

Antibody engineering?The development of therapeutic antibodies is a time and cost intensive process. Biological and physicochemical properties of the lead molecules influence almost every step in the development. Investing into antibody engineering and lead optimisation during early development pays off in later steps and does not only accelerate the programme, but also increases the chance of success.

8 November 2023

Cancer data: a dive into the depths

Background

As Big Data analytics begin to inspire medical decisionmaking, companies and scientists have gone to war over access to data derived from patient biopsies. Cancer profiling is a seminal situation. While some companies are seeking to profit from approaches to advanced mutation analysis, researchers are vociferous in demanding open access to proprietary databases behind company firewalls.

9 January 2018